SureScripts-led Coalition Launches Consumer Campaign to Jump Start eRX


By Neil Versel

April 29, 2008 | Expect to see “E-prescriptions filled here” and “give your prescription a head start” signs at thousands of pharmacies nationwide starting today as part of a first-ever nationwide consumer campaign to raise awareness about the availability and benefits of electronic prescribing.

Led by ePrescribing connectivity network provider SureScripts (Alexandria,Va.), a coalition of health care, technology and retail organizations on Tuesday is hoping the campaign will jump-start patient demand for the technology, which SureScripts says was used for less than 3 percent of the more than 1.4 billion retail prescriptions filled in the U.S. last year. SureScripts, which runs the Pharmacy Health Information Exchange, says only 6 percent of U.S. physicians can send true electronic prescriptions.

This estimate counts only prescriptions transmitted by electronic data interchange, not by fax. Last year, the Centers for Medicare and Medicaid Services (CMS) changed the definition of ePrescribing under Medicare Part D to exclude computer-generated faxes. Faxed orders from ePrescribing programs for Medicare beneficiaries essentially will become illegal on Jan. 1, 2009.

“The next time you or anyone you know goes to the doctor’s office and the doctor takes out their pad and pen to write a prescription, take the opportunity to ask your doctor for an ePrescription instead,” SureScripts chief marketing officer Tammy Lewis says in a statement provided to Digital HealthCare & Productivity ahead of today’s program introduction in Washington.

In addition to the signage, the campaign includes an informational Web site, www.LearnAboutEprescriptions.com, for the public to search for names of local physicians with ePrescribing in place. The site also lets the public e-mail or print out information for their doctors to learn about the time savings and error reduction that ePrescribing can bring.

Indeed, the groups are promoting ePrescribing as a way to avoid two trips to the pharmacy, one to drop off a script and another to pick up the medication. “The opportunity to eliminate unnecessary trips and reduce time spent at the pharmacy can make a huge difference,” says Lewis, who has three children 9 or younger. “I know what it’s like to have a sick child in the back seat in need of medication.”

Lewis was to be joined at the Washington event by representatives from national and regional pharmacy chains, including CVS Caremark, Wal-Mart, Rite Aid, Walgreens, Longs Drugs, and Kerr Drug. The program also has support from the AARP, the National Association of Chain Drug Stores, and the National Community Pharmacists Association. The latter two groups co-own SureScripts.

SureScripts has hinted at this consumer-awareness program since late last year. (See “Hutchinson Steps Down as SureScripts Top Exec, Ratliff Moves Up.”) Since that time, SureScripts joined with the American Academy of Family Physicians, the Medical Group Management Association, technology giant Intel, and health insurer Humana, to found the Center for Improving Medication Management and produce an ePrescribing readiness assessment for physician practices. That assessment, available at www.GetRxConnected.com, now has the support of additional physician organizations.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data. Download now



SGI's Meeting Today’s Computational Needs for Science
The quest to better understand disease mechanisms and find new treatments is driven by new laboratory technologies and ever-more sophisticated modeling and simulation efforts. As such, life sciences R&D investigations increasingly are relying on more powerful computing resources. The challenge is how to accommodate the broad mix of applications.

Addressing this issue, this paper produced by the Bio-IT World Custom Publishing Group discusses a new SGI Hybrid Computing Environment approach. It optimally uses shared memory systems, multi-processor clusters, and FPGAs to accelerate computational workflows. Download This Free Paper



SGI's Supercharging Proteomics Discovery
The deeper study of proteins and their interactions can reveal scientific information once considered nearly untouchable to scientists and researchers. Today, unprecedented advancements in computing power are enabling the creation of mounds of proteomic based data along with the accompanying bottlenecks data can create.

Rather than just “simplify the experiment” to fit the computational resources an alternative is now available with the SGI Proteomics Appliance. This complimentary white paper, produced by the Bio-IT World Custom Publishing Group, looks at ways to use the Proteomic Appliance to handle the most intensive proteomics computing tasks facing science today. Download This Free Paper



Life Science Webcasts & Podcasts

Waters

Streamlining the Chromatographic Method Validation Process

Waters® Empower™ 2 Method Validation Manager (MVM) is a business-critical, compliant-ready software that reduces time and costs required to perform chromatographic method validation by as much as 80%. Learn in this podcast how MVM streamlines the method validation process and allows the entire process to be efficiently performed within Empower 2, so fewer software applications need be deployed, validated, and maintained. Download Now


More Podcasts

Job Openings

Lilly Singapore Center for Drug Discovery (LSCDD) - Associate Director of Informatics
Lead and mentor a strong team for the Bioinformatics group at the Integrative Computational Sciences (ICS) department at LSCDD towards the development of novel algorithms, data analysis methods and software tools for drug discovery. Work closely with the Software Engineering group at ICS, and collaborate with the Discovery IT organization in Europe and USA. For additional information, or to apply visit: LSCDD

Lilly Singapore Center for Drug Discovery (LSCDD) - Senior Software Engineer
Join a strong team of software engineers in our Integrative Computational Sciences (ICS) at LSCDD. Collaborate with, and help develop integrated applications to process and visualize data from cutting-edge technologies used by scientists at Lilly Research Labs (LRL) and the Drug Discovery Research (DDR) teams. The Software Engineering team provides computational tools and tailored software solutions that enable the global effort of Tailored Therapeutics; ‘The Right Drug, at The Right Dose for The Right Patient at The Right Time'. For additional information, or to apply visit: LSCDD

Related Resources & Products

Novel Approaches to Lead Optimization



For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to [email protected].